Wolfe Research Starts Teva Pharma (TEVA) at Peerperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Bearish Options Positioning in Teva Pharma (TEVA) Targets Downside in Shares Through January -Susquehanna
July 22, 2019 1:48 PM EDTSusquehanna options strategist Alison Edwards notes bearish options positioning in Teva Pharma (NYSE: TEVA), as investors bought 22k Jan 9 Puts for $2.10. The investors buy volatility, suggesting the shares have an increased probability to trade below their breakeven of ~$6.90 (-10%).
... More
